Ningbo David Medical Device Co Ltd (300314) — Strategic Asset Allocation Index
Ningbo David Medical Device Co Ltd (300314) has a Strategic Asset Allocation Index of 17.1% as of June 2023. Strategic assets (PP&E of CN¥189.29 Million plus long-term investments of CN¥-) total CN¥189.29 Million, measured against net assets of CN¥1.11 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check asset resilience ratio of Ningbo David Medical Device Co Ltd to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Ningbo David Medical Device Co Ltd Strategic Asset Allocation Index (2009–2021)
This chart shows how Ningbo David Medical Device Co Ltd's Strategic Asset Allocation Index has evolved across 13 annual periods from 2009 to 2021. As of June 2023, the index stands at 17.1%, representing strategic assets of CN¥189.29 Million against net assets of CN¥1.11 Billion CNY. See how financially flexible is Ningbo David Medical Device Co Ltd to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Ningbo David Medical Device Co Ltd (2009–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Ningbo David Medical Device Co Ltd from 2009 to 2021, covering 13 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see how much is Ningbo David Medical Device Co Ltd worth.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 20.1% | CN¥199.09 Million | CN¥199.09 Million | CN¥- | CN¥990.53 Million | ▼ -2.4 pp |
| 2020 | 22.5% | CN¥214.45 Million | CN¥214.45 Million | CN¥- | CN¥953.52 Million | ▼ -3.9 pp |
| 2019 | 26.4% | CN¥218.73 Million | CN¥218.73 Million | CN¥- | CN¥828.85 Million | ▼ -6.9 pp |
| 2018 | 33.3% | CN¥263.59 Million | CN¥229.84 Million | CN¥33.75 Million | CN¥792.71 Million | ▼ -6.1 pp |
| 2017 | 39.3% | CN¥306.07 Million | CN¥239.84 Million | CN¥66.23 Million | CN¥778.30 Million | ▲ +3.4 pp |
| 2016 | 36.0% | CN¥269.30 Million | CN¥194.34 Million | CN¥74.96 Million | CN¥748.55 Million | ▼ -0.2 pp |
| 2015 | 36.1% | CN¥252.24 Million | CN¥177.21 Million | CN¥75.03 Million | CN¥697.90 Million | ▲ +13.7 pp |
| 2014 | 22.4% | CN¥149.96 Million | CN¥149.96 Million | CN¥- | CN¥668.97 Million | ▼ -1.6 pp |
| 2013 | 24.0% | CN¥150.76 Million | CN¥150.76 Million | CN¥- | CN¥628.16 Million | ▲ +4.8 pp |
| 2012 | 19.2% | CN¥113.44 Million | CN¥113.44 Million | CN¥- | CN¥592.09 Million | ▼ -53.3 pp |
| 2011 | 72.4% | CN¥118.95 Million | CN¥118.95 Million | CN¥- | CN¥164.25 Million | ▼ -10.4 pp |
| 2010 | 82.9% | CN¥91.38 Million | CN¥91.38 Million | CN¥- | CN¥110.28 Million | ▼ -33.9 pp |
| 2009 | 116.8% | CN¥92.93 Million | CN¥92.93 Million | CN¥- | CN¥79.57 Million | — |